Anti-Human ITGA4 & ITGB7 Recombinant Antibody(Vedolizumab)
-
产品编号
YR1198
-
别名
科研级 Vedolizumab ( 维多组单抗 ), Anti-ITGA4 & ITGB7 Recombinant Antibody, Research Grade Vedolizumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Vedolizumab ( 维多组单抗 ), Anti-ITGA4 & ITGB7 Recombinant Antibody, Research Grade Vedolizumab |
| Catalog Number | YR1198 |
| Molecular Name | Vedolizumab |
| CAS Number | 943609-66-3 |
| Molecular Weight | 146.81 kDa |
| Target | ITGA4 & ITGB7[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Solanezumab (proposed INN, LY2062430) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease. The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials. |
| Application | FCM, IP, ELISA, Neut, FuncS, IF |
| Remarks | This product is for research use only. |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5栋
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 8:30-18:00 -
-
0
-
